In 2024, DeepMind and Isomorphic Labs released a significantly improved successor to the model. AlphaFold 3 delivers a more ...
Morning Overview on MSN
IBM, Riken, and the Cleveland Clinic simulated a 12,000-atom protein by linking quantum computers with Japanese supercomputers
In late May 2026, a research team from IBM, Japan’s RIKEN institute, and the Cleveland Clinic reported that they had ...
AI is moving beyond biology to decode human history, searching for hidden patterns that explain how societies rise and ...
Two approaches to AI in preclinical drug discovery are diverging, from multi-thousand GPU systems to models with only a ...
ByteDance's drug unit showed an AI-designed IL-17 inhibitor at a Boston conference. The molecule targets interactions pharma called undruggable. Only trials will tell.
AGI may be achieved by 2030, transforming AI development with groundbreaking advancements and increased productivity.
The Ministry of Science and ICT is joining hands with Google DeepMind to establish a collaborative framework for the ...
Domestic researchers have made significant progress toward developing artificial intelligence (AI)-based antibody drugs that ...
At AACR 2026, researchers discussed the promise and challenges of bringing AI-powered tools into cancer research and clinical ...
Expanding HanchorBio's data-enabled approach from molecule design to portfolio and market insight TAIPEI and SHANGHAI and SAN ...
For years, AI drug discovery has been judged on benchmark performance. Now, a set of studies shows what happens when those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results